Highlights Arecor Therapeutics plc

Equities

AREC

GB00BMWLM973

Biotechnology & Medical Research

Market Closed - London S.E. Other stock markets 11:35:16 2025-06-20 am EDT			5-day change	1st Jan Change
43.50 ^GBX	0.00%		0.00%	-40.82%

Jun. 02	Arecor Therapeutics plc Announces Alan Smith to Retire from its Board, Effective 2 June 2025	CI
May. 26	Arecor Therapeutics plc - Special Call

Highlights

Arecor shares climb 18% on collaboration with Skye Bioscience	May. 19	AN
Arecor Partners with Skye Bioscience to Enhance Obesity Drug Formulation	May. 19	MT
Skye Bioscience, Inc. Establishes Partnership with Arecor Therapeutics to Develop Enhanced Formulation of Obesity Candidate Nimacimab	May. 19	CI
Big Technologies names new CEO; Van Elle's signs deal	May. 08	AN
Arecor Sells Non-Ogluo Tetris Pharma Product Rights to Aspire Pharma	May. 08	MT
Arecor Therapeutics sees "significant future growth" as revenue rises	Apr. 22	AN
Earnings Flash (AREC.L) Arecor Therapeutics Reports FY24 Revenue GBP5.1M	Apr. 22	MT
Earnings Flash (AREC.L) Arecor Therapeutics Posts FY24 Loss GBP-0.31	Apr. 22	MT
Arecor Therapeutics plc Reports Earnings Results for the Full Year Ended December 31, 2024	Apr. 22	CI
Arecor Therapeutics plc Enters Collaboration with Major Global Pharmaceutical Partner	Mar. 26	CI
Arecor Therapeutics strikes deal for development of peptide therapy	Mar. 12	AN
Arecor Therapeutics Enters Partnership to Develop Peptide Therapy Formulations	Mar. 12	MT
Arecor Therapeutics plc Announces Formulation Development Collaboration with Biopharmaceutical Company to Develop Novel Formulation of Peptide Therapeutics	Mar. 12	CI
Arecor Therapeutics confident for the future as revenue rises	Feb. 03	AN
Arecor Therapeutics Says Non-Clinical PK Data For Oral GLP-1 On Track To Be Delivered In H1'25	Feb. 03	RE
Arecor Therapeutics shares tumble as plans Tetris wind-down	Jan. 10	AN
Arecor Therapeutics to Shutter Tetris Pharma Unit; Ends License Deal with Xeris	Jan. 10	MT
Arecor Therapeutics signs new drug licensing agreement	Dec. 30	AN
Arecor Therapeutics plc Signs Exclusive Licensing Agreement for Ready-To-Dilute Formulation of Speciality Hospital Product At351	Dec. 30	CI
EARNINGS: Hansard Global profit down; Flowtech cuts outlook	24-09-26	AN
Earnings Flash (AREC.L) ARECOR THERAPEUTICS Posts H1 Revenue GBP2M	24-09-26	MT
Earnings Flash (AREC.L) ARECOR THERAPEUTICS Posts H1 Loss GBP-0.15	24-09-26	MT
Arecor Therapeutics plc Reports Earnings Results for the Half Year Ended June 30, 2024	24-09-26	CI
Arecor Therapeutics plc Presents Positive Data from Phase I Clinical Trial of Ultra-Concentrated, Ultra-Rapid Acting Insulins	24-09-11	CI
Arecor Therapeutics Completes Retail Offer	24-07-23	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Arecor Therapeutics plc

Equities

AREC

GB00BMWLM973

Biotechnology & Medical Research

Highlights

Filters